IRONWOOD PHARMACEUTICALS INC (IRWD) Form 8-K — Jun 18, 2026
$IRWDForm 8-KItems 5.02, 5.07, 9.01Filed Jun 18, 2026, 4:14 PM ET0001104659-26-075730Original filing
Ironwood Pharmaceuticals announced the voting results from its 2026 Annual Meeting of Stockholders held on June 16, 2026. Shareholders approved an amendment to the company's 2019 Equity Incentive Plan, increasing the number of authorized Class A common shares available for issuance by 10 million shares. The voting results confirmed the election of eight director nominees, including Mark Currie and Alexander Denner, to serve until the 2027 Annual Meeting.
Key figures
- Total plan shares
- 26000000
- Shares added to plan
- 10000000
Price after filing
1 day: 0.0%7 days: +8.5%30 days: +9.3%
Close on the filing date to close N calendar days later (from $3.54). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.